Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USA.
第一作者:
K W,Douglas
第一单位:
HPC Transplant Programme, Beatson West of Scotland Cancer Centre, Glasgow, UK. kenneth.douglas@nhs.net
作者:
医学主题词
成年人(Adult);老年人(Aged);抗HIV药(Anti-HIV Agents);苄胺类(Benzylamines);血液成分除去法(Blood Component Removal);剂量效应关系, 药物(Dose-Response Relationship, Drug);女(雌)性(Female);粒细胞集落刺激因子(Granulocyte Colony-Stimulating Factor);造血干细胞动员(Hematopoietic Stem Cell Mobilization);杂环化合物(Heterocyclic Compounds);人类(Humans);肾移植(Kidney Transplantation);男(雄)性(Male);中年人(Middle Aged);多发性骨髓瘤(Multiple Myeloma);外周血干细胞移植(Peripheral Blood Stem Cell Transplantation);肾透析(Renal Dialysis);肾功能不全(Renal Insufficiency);移植, 自体(Transplantation, Autologous);移植, 同种(Transplantation, Homologous)
DOI
10.1038/bmt.2011.9
PMID
21358693
发布时间
2021-12-03
- 浏览21
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



